Shrinking the lymphatic filariasis map: update on diagnostic tools for mapping and transmission monitoring.
Identifieur interne : 002522 ( Main/Exploration ); précédent : 002521; suivant : 002523Shrinking the lymphatic filariasis map: update on diagnostic tools for mapping and transmission monitoring.
Auteurs : Maria P. Rebollo [Royaume-Uni] ; Moses John Bockarie [Royaume-Uni]Source :
- Parasitology [ 1469-8161 ] ; 2014.
Descripteurs français
- KwdFr :
- Afrique (épidémiologie), Albendazole (administration et posologie), Animaux, Anticorps antihelminthe (sang), Enquêtes et questionnaires, Femelle, Filaricides (administration et posologie), Filariose lymphatique (), Filariose lymphatique (diagnostic), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Humains, Immunochromatographie, Microfilaria, Prévalence, Réaction de polymérisation en chaîne, Résultat thérapeutique, Tests diagnostiques courants, Vecteurs de maladie, Wuchereria bancrofti (), Wuchereria bancrofti (génétique), Wuchereria bancrofti (immunologie), Wuchereria bancrofti (isolement et purification), Épidémiosurveillance, Éradication de maladie.
- MESH :
- administration et posologie : Albendazole, Filaricides.
- diagnostic : Filariose lymphatique.
- génétique : Wuchereria bancrofti.
- immunologie : Wuchereria bancrofti.
- isolement et purification : Wuchereria bancrofti.
- sang : Anticorps antihelminthe.
- traitement médicamenteux : Filariose lymphatique.
- épidémiologie : Afrique, Filariose lymphatique.
- Animaux, Enquêtes et questionnaires, Femelle, Filariose lymphatique, Humains, Immunochromatographie, Microfilaria, Prévalence, Réaction de polymérisation en chaîne, Résultat thérapeutique, Tests diagnostiques courants, Vecteurs de maladie, Wuchereria bancrofti, Épidémiosurveillance, Éradication de maladie.
English descriptors
- KwdEn :
- Africa (epidemiology), Albendazole (administration & dosage), Animals, Antibodies, Helminth (blood), Diagnostic Tests, Routine, Disease Eradication, Disease Vectors, Elephantiasis, Filarial (diagnosis), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Epidemiological Monitoring, Female, Filaricides (administration & dosage), Humans, Immunochromatography, Microfilariae, Polymerase Chain Reaction, Prevalence, Surveys and Questionnaires, Treatment Outcome, Wuchereria bancrofti (drug effects), Wuchereria bancrofti (genetics), Wuchereria bancrofti (immunology), Wuchereria bancrofti (isolation & purification).
- MESH :
- chemical , administration & dosage : Albendazole, Filaricides.
- chemical , blood : Antibodies, Helminth.
- diagnosis : Elephantiasis, Filarial.
- drug effects : Wuchereria bancrofti.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : Africa, Elephantiasis, Filarial.
- genetics : Wuchereria bancrofti.
- immunology : Wuchereria bancrofti.
- isolation & purification : Wuchereria bancrofti.
- prevention & control : Elephantiasis, Filarial.
- Animals, Diagnostic Tests, Routine, Disease Eradication, Disease Vectors, Epidemiological Monitoring, Female, Humans, Immunochromatography, Microfilariae, Polymerase Chain Reaction, Prevalence, Surveys and Questionnaires, Treatment Outcome.
Abstract
Lymphatic filariasis (LF), which is highly endemic in 73 countries worldwide, is targeted for elimination by 2020. The strategy for achieving this goal is based on 4 sequential programmatic steps: mapping, Mass drug administration (MDA) implementation, post-MDA surveillance and verification of LF elimination. All 4 stages of the implementation process are dependent on the availability of user friendly and highly sensitive rapid diagnostic tools. By the end of 2012, 59 countries had completed mapping for LF and Eritrea was the only country yet to start the process. Rolling out new diagnostic tools to facilitate the mapping process will enable an accelerated shrinking of the LF map to zero endemic countries by 2020. When the Global Programme to Eliminate Lymphatic Filariasis was launched in 2000, diagnostic tools for LF were limited to clinical examination, detection of microfilaria (MF) by microscopy in night blood samples and detection of antibodies to native-antigen preparations. There has been a significant improvement in the traditional LF diagnostic methods in recent years and some new tools are now available. This paper provides an update on the human diagnostic tests available for LF and their current applications as tools in mapping and transmission monitoring. The values of entomological indicators and parasite detection and speciation methods applied to vector populations are also discussed.
DOI: 10.1017/S0031182014001231
PubMed: 25225828
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001314
- to stream PubMed, to step Curation: 001314
- to stream PubMed, to step Checkpoint: 001314
- to stream Ncbi, to step Merge: 006B05
- to stream Ncbi, to step Curation: 006B05
- to stream Ncbi, to step Checkpoint: 006B05
- to stream Main, to step Merge: 002525
- to stream Main, to step Curation: 002522
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Shrinking the lymphatic filariasis map: update on diagnostic tools for mapping and transmission monitoring.</title><author><name sortKey="Rebollo, Maria P" sort="Rebollo, Maria P" uniqKey="Rebollo M" first="Maria P" last="Rebollo">Maria P. Rebollo</name><affiliation wicri:level="1"><nlm:affiliation>Department of Parasitology,Liverpool School of Tropical Medicine,Centre for Neglected Tropical Diseases, Pembroke Place, Liverpool L3 5QA,UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Parasitology,Liverpool School of Tropical Medicine,Centre for Neglected Tropical Diseases, Pembroke Place, Liverpool L3 5QA</wicri:regionArea><wicri:noRegion>Liverpool L3 5QA</wicri:noRegion></affiliation></author><author><name sortKey="Bockarie, Moses John" sort="Bockarie, Moses John" uniqKey="Bockarie M" first="Moses John" last="Bockarie">Moses John Bockarie</name><affiliation wicri:level="1"><nlm:affiliation>Department of Parasitology,Liverpool School of Tropical Medicine,Centre for Neglected Tropical Diseases, Pembroke Place, Liverpool L3 5QA,UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Parasitology,Liverpool School of Tropical Medicine,Centre for Neglected Tropical Diseases, Pembroke Place, Liverpool L3 5QA</wicri:regionArea><wicri:noRegion>Liverpool L3 5QA</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25225828</idno><idno type="pmid">25225828</idno><idno type="doi">10.1017/S0031182014001231</idno><idno type="wicri:Area/PubMed/Corpus">001314</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001314</idno><idno type="wicri:Area/PubMed/Curation">001314</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001314</idno><idno type="wicri:Area/PubMed/Checkpoint">001314</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001314</idno><idno type="wicri:Area/Ncbi/Merge">006B05</idno><idno type="wicri:Area/Ncbi/Curation">006B05</idno><idno type="wicri:Area/Ncbi/Checkpoint">006B05</idno><idno type="wicri:Area/Main/Merge">002525</idno><idno type="wicri:Area/Main/Curation">002522</idno><idno type="wicri:Area/Main/Exploration">002522</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Shrinking the lymphatic filariasis map: update on diagnostic tools for mapping and transmission monitoring.</title><author><name sortKey="Rebollo, Maria P" sort="Rebollo, Maria P" uniqKey="Rebollo M" first="Maria P" last="Rebollo">Maria P. Rebollo</name><affiliation wicri:level="1"><nlm:affiliation>Department of Parasitology,Liverpool School of Tropical Medicine,Centre for Neglected Tropical Diseases, Pembroke Place, Liverpool L3 5QA,UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Parasitology,Liverpool School of Tropical Medicine,Centre for Neglected Tropical Diseases, Pembroke Place, Liverpool L3 5QA</wicri:regionArea><wicri:noRegion>Liverpool L3 5QA</wicri:noRegion></affiliation></author><author><name sortKey="Bockarie, Moses John" sort="Bockarie, Moses John" uniqKey="Bockarie M" first="Moses John" last="Bockarie">Moses John Bockarie</name><affiliation wicri:level="1"><nlm:affiliation>Department of Parasitology,Liverpool School of Tropical Medicine,Centre for Neglected Tropical Diseases, Pembroke Place, Liverpool L3 5QA,UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Parasitology,Liverpool School of Tropical Medicine,Centre for Neglected Tropical Diseases, Pembroke Place, Liverpool L3 5QA</wicri:regionArea><wicri:noRegion>Liverpool L3 5QA</wicri:noRegion></affiliation></author></analytic><series><title level="j">Parasitology</title><idno type="eISSN">1469-8161</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Africa (epidemiology)</term><term>Albendazole (administration & dosage)</term><term>Animals</term><term>Antibodies, Helminth (blood)</term><term>Diagnostic Tests, Routine</term><term>Disease Eradication</term><term>Disease Vectors</term><term>Elephantiasis, Filarial (diagnosis)</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Epidemiological Monitoring</term><term>Female</term><term>Filaricides (administration & dosage)</term><term>Humans</term><term>Immunochromatography</term><term>Microfilariae</term><term>Polymerase Chain Reaction</term><term>Prevalence</term><term>Surveys and Questionnaires</term><term>Treatment Outcome</term><term>Wuchereria bancrofti (drug effects)</term><term>Wuchereria bancrofti (genetics)</term><term>Wuchereria bancrofti (immunology)</term><term>Wuchereria bancrofti (isolation & purification)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Afrique (épidémiologie)</term><term>Albendazole (administration et posologie)</term><term>Animaux</term><term>Anticorps antihelminthe (sang)</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Filaricides (administration et posologie)</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (diagnostic)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (épidémiologie)</term><term>Humains</term><term>Immunochromatographie</term><term>Microfilaria</term><term>Prévalence</term><term>Réaction de polymérisation en chaîne</term><term>Résultat thérapeutique</term><term>Tests diagnostiques courants</term><term>Vecteurs de maladie</term><term>Wuchereria bancrofti ()</term><term>Wuchereria bancrofti (génétique)</term><term>Wuchereria bancrofti (immunologie)</term><term>Wuchereria bancrofti (isolement et purification)</term><term>Épidémiosurveillance</term><term>Éradication de maladie</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Albendazole</term><term>Filaricides</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Helminth</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Albendazole</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Africa</term><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antihelminthe</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Afrique</term><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Diagnostic Tests, Routine</term><term>Disease Eradication</term><term>Disease Vectors</term><term>Epidemiological Monitoring</term><term>Female</term><term>Humans</term><term>Immunochromatography</term><term>Microfilariae</term><term>Polymerase Chain Reaction</term><term>Prevalence</term><term>Surveys and Questionnaires</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Filariose lymphatique</term><term>Humains</term><term>Immunochromatographie</term><term>Microfilaria</term><term>Prévalence</term><term>Réaction de polymérisation en chaîne</term><term>Résultat thérapeutique</term><term>Tests diagnostiques courants</term><term>Vecteurs de maladie</term><term>Wuchereria bancrofti</term><term>Épidémiosurveillance</term><term>Éradication de maladie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphatic filariasis (LF), which is highly endemic in 73 countries worldwide, is targeted for elimination by 2020. The strategy for achieving this goal is based on 4 sequential programmatic steps: mapping, Mass drug administration (MDA) implementation, post-MDA surveillance and verification of LF elimination. All 4 stages of the implementation process are dependent on the availability of user friendly and highly sensitive rapid diagnostic tools. By the end of 2012, 59 countries had completed mapping for LF and Eritrea was the only country yet to start the process. Rolling out new diagnostic tools to facilitate the mapping process will enable an accelerated shrinking of the LF map to zero endemic countries by 2020. When the Global Programme to Eliminate Lymphatic Filariasis was launched in 2000, diagnostic tools for LF were limited to clinical examination, detection of microfilaria (MF) by microscopy in night blood samples and detection of antibodies to native-antigen preparations. There has been a significant improvement in the traditional LF diagnostic methods in recent years and some new tools are now available. This paper provides an update on the human diagnostic tests available for LF and their current applications as tools in mapping and transmission monitoring. The values of entomological indicators and parasite detection and speciation methods applied to vector populations are also discussed.</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><country name="Royaume-Uni"><noRegion><name sortKey="Rebollo, Maria P" sort="Rebollo, Maria P" uniqKey="Rebollo M" first="Maria P" last="Rebollo">Maria P. Rebollo</name></noRegion><name sortKey="Bockarie, Moses John" sort="Bockarie, Moses John" uniqKey="Bockarie M" first="Moses John" last="Bockarie">Moses John Bockarie</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002522 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002522 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25225828
|texte= Shrinking the lymphatic filariasis map: update on diagnostic tools for mapping and transmission monitoring.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25225828" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |